Le syndrome des antiphospholipides en néphrologie. Atteinte rénale et aspects pratiques de la prise en charge
Le syndrome des antiphospholipides est une thrombophilie caractérisée par l’association d’un événement clinique thrombotique (artériel et/ou veineux) ou obstétrical, associé à la présence durable d’anticorps antiphospholipides. L’atteinte pouvant toucher l’ensemble de l’arbre vasculaire, une atteint...
Saved in:
Published in | Néphrologie & thérapeutique Vol. 10; no. 1; pp. 1 - 9 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | French |
Published |
Issy-les-Moulineaux
Elsevier SAS
01.02.2014
Elsevier Masson Elsevier Masson (jusqu'en 2022) / John Libbey Eurotext (à partir de 2023) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Le syndrome des antiphospholipides est une thrombophilie caractérisée par l’association d’un événement clinique thrombotique (artériel et/ou veineux) ou obstétrical, associé à la présence durable d’anticorps antiphospholipides. L’atteinte pouvant toucher l’ensemble de l’arbre vasculaire, une atteinte rénale est fréquemment associée avec la description maintenant bien codifiée de la néphropathie associée au syndrome des antiphospholipides. Nous proposons dans cette revue des recommandations actualisées sur la prise en charge du syndrome des antiphospholipides en néphrologie. La thérapeutique se base sur une anticoagulation plus ou moins une antiagrégation à long terme en fonction des événements cliniques sans oublier le recours à une néphroprotection classique (contrôle strict de la pression artérielle avec notamment des thérapeutiques bloquant le système rénine–angiotensine–aldostérone). Le syndrome catastrophique des antiphospholipides est une complication extrêmement grave pouvant mettre en jeu le pronostic vital du patient. Celui-ci justifie une attention toute particulière, ainsi qu’une prévention dans les situations à risque. Nous illustrons également les difficultés de prise en charge au long cours de ces patients, tant en dialyse qu’en transplantation rénale.
The antiphospholipid syndrome is a thrombophilia characterized by the combination of arterial and/or venous thrombotic events or obstetric clinical events, associated with persistent presence of antiphospholipid antibodies. In this syndrome, thromboses may affect all of the vascular tree, renal damage is frequently associated with a specific antiphospholipid syndrome nephropathy. We propose in this review to provide updated recommendations on the management of antiphospholipid syndrome in nephrology. Treatment is based on long-term anticoagulant therapy with or without antiplatelet agents according to clinical events. The use of a conventional nephroprotection must not be forgotten (strict control of blood pressure with drugs blocking the renin–angiotensin–aldosterone system). Catastrophic antiphospholipid syndrome is an extremely severe complication which can threaten the vital prognosis of the patient. This justifies particular surveillance, as well as prevention in high-risk situations. We also illustrate the difficulties of long-term management in these patients, both in dialysis or kidney transplantation. |
---|---|
AbstractList | Le syndrome des antiphospholipides est une thrombophilie caractérisée par l’association d’un événement clinique thrombotique (artériel et/ou veineux) ou obstétrical, associé à la présence durable d’anticorps antiphospholipides. L’atteinte pouvant toucher l’ensemble de l’arbre vasculaire, une atteinte rénale est fréquemment associée avec la description maintenant bien codifiée de la néphropathie associée au syndrome des antiphospholipides. Nous proposons dans cette revue des recommandations actualisées sur la prise en charge du syndrome des antiphospholipides en néphrologie. La thérapeutique se base sur une anticoagulation plus ou moins une antiagrégation à long terme en fonction des événements cliniques sans oublier le recours à une néphroprotection classique (contrôle strict de la pression artérielle avec notamment des thérapeutiques bloquant le système rénine–angiotensine–aldostérone). Le syndrome catastrophique des antiphospholipides est une complication extrêmement grave pouvant mettre en jeu le pronostic vital du patient. Celui-ci justifie une attention toute particulière, ainsi qu’une prévention dans les situations à risque. Nous illustrons également les difficultés de prise en charge au long cours de ces patients, tant en dialyse qu’en transplantation rénale.
The antiphospholipid syndrome is a thrombophilia characterized by the combination of arterial and/or venous thrombotic events or obstetric clinical events, associated with persistent presence of antiphospholipid antibodies. In this syndrome, thromboses may affect all of the vascular tree, renal damage is frequently associated with a specific antiphospholipid syndrome nephropathy. We propose in this review to provide updated recommendations on the management of antiphospholipid syndrome in nephrology. Treatment is based on long-term anticoagulant therapy with or without antiplatelet agents according to clinical events. The use of a conventional nephroprotection must not be forgotten (strict control of blood pressure with drugs blocking the renin–angiotensin–aldosterone system). Catastrophic antiphospholipid syndrome is an extremely severe complication which can threaten the vital prognosis of the patient. This justifies particular surveillance, as well as prevention in high-risk situations. We also illustrate the difficulties of long-term management in these patients, both in dialysis or kidney transplantation. The antiphospholipid syndrome is a thrombophilia characterized by the combination of arterial and/or venous thrombotic events or obstetric clinical events, associated with persistent presence of antiphospholipid antibodies. In this syndrome, thromboses may affect all of the vascular tree, renal damage is frequently associated with a specific antiphospholipid syndrome nephropathy. We propose in this review to provide updated recommendations on the management of antiphospholipid syndrome in nephrology. Treatment is based on long-term anticoagulant therapy with or without antiplatelet agents according to clinical events. The use of a conventional nephroprotection must not be forgotten (strict control of blood pressure with drugs blocking the renin-angiotensin-aldosterone system). Catastrophic antiphospholipid syndrome is an extremely severe complication which can threaten the vital prognosis of the patient. This justifies particular surveillance, as well as prevention in high-risk situations. We also illustrate the difficulties of long-term management in these patients, both in dialysis or kidney transplantation. Le syndrome des antiphospholipides est une thrombophilie caractérisée par l’association d’un événement clinique thrombotique (artériel et/ou veineux) ou obstétrical, associé à la présence durable d’anticorps antiphospholipides. L’atteinte pouvant toucher l’ensemble de l’arbre vasculaire, une atteinte rénale est fréquemment associée avec la description maintenant bien codifiée de la néphropathie associée au syndrome des antiphospholipides. Nous proposons dans cette revue des recommandations actualisées sur la prise en charge du syndrome des antiphospholipides en néphrologie. La thérapeutique se base sur une anticoagulation plus ou moins une antiagrégation à long terme en fonction des événements cliniques sans oublier le recours à une néphroprotection classique (contrôle strict de la pression artérielle avec notamment des thérapeutiques bloquant le système rénine–angiotensine–aldostérone). Le syndrome catastrophique des antiphospholipides est une complication extrêmement grave pouvant mettre en jeu le pronostic vital du patient. Celui-ci justifie une attention toute particulière, ainsi qu’une prévention dans les situations à risque. Nous illustrons également les difficultés de prise en charge au long cours de ces patients, tant en dialyse qu’en transplantation rénale. |
Author | Champigneulle, Jacqueline Dekeyser, Manon Wahl, Denis Zuily, Stéphane Frimat, Luc Eschwège, Valérie Perret-Guillaume, Christine |
Author_xml | – sequence: 1 givenname: Manon surname: Dekeyser fullname: Dekeyser, Manon email: manondekeyser@gmail.com organization: Service de néphrologie-hémodialyse-transplantation, CHU de Nancy, rue du Morvan, 54511 Vandœuvre-lès-Nancy, France – sequence: 2 givenname: Stéphane surname: Zuily fullname: Zuily, Stéphane organization: Service de médecine vasculaire, centre de compétence régional des maladies vasculaires rares et systémiques et auto-immunes, institut lorrain du cœur et des vaisseaux Louis-Mathieu, CHU de Nancy, rue du Morvan, 54511 Vandœuvre-lès-Nancy, France – sequence: 3 givenname: Jacqueline surname: Champigneulle fullname: Champigneulle, Jacqueline organization: Laboratoire d’anatomopathologie, CHU de Nancy, rue du Morvan, 54511 Vandœuvre-lès-Nancy, France – sequence: 4 givenname: Valérie surname: Eschwège fullname: Eschwège, Valérie organization: Laboratoire d’hématologie biologique, CHU de Nancy, rue du Morvan, 54511 Vandœuvre-lès-Nancy, France – sequence: 5 givenname: Luc surname: Frimat fullname: Frimat, Luc organization: Service de néphrologie-hémodialyse-transplantation, CHU de Nancy, rue du Morvan, 54511 Vandœuvre-lès-Nancy, France – sequence: 6 givenname: Christine surname: Perret-Guillaume fullname: Perret-Guillaume, Christine organization: Pôle de gérontologie-soins palliatifs, CHU de Nancy, rue du Morvan, 54511 Vandœuvre-lès-Nancy, France – sequence: 7 givenname: Denis surname: Wahl fullname: Wahl, Denis organization: Service de médecine vasculaire, centre de compétence régional des maladies vasculaires rares et systémiques et auto-immunes, institut lorrain du cœur et des vaisseaux Louis-Mathieu, CHU de Nancy, rue du Morvan, 54511 Vandœuvre-lès-Nancy, France |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28130788$$DView record in Pascal Francis https://hal.univ-lorraine.fr/hal-01791299$$DView record in HAL |
BookMark | eNp9kM1u3CAQx1GVqPlo36AHLj30YJcB1sCl0ipqPqSVeknPiMXjLCsHXHAj5ZHyHHmxYjnKsQc0zPD_zzC_C3ISU0RCvgBrgUH3_dhGnA45tZyBaJlqRac_kHPQijcGlDqpd9WZRvHN5oxclHJkTGgJ8JGc8RoEGH1O0g5peY59To9IeyzUxTlMh1TqGcMUlhJGGl9fllljegjY0u08Y4gz0vz6Et2IFGfqyoR-LnTKbg5__lZbj3R0NQ8Flxb-4PIDfiKngxsLfn6Ll-T39c_7q9tm9-vm7mq7azx0UjdccgV-rxgbpHJOy8GBQCcEdnU3pzsuNxI3noHx3EuzN9rjXhlZH0znvbgk39a-Bzfa-odHl59tcsHebnd2qTFQBrgxT1C1ctX6nErJOLwbgNmFtT3albVdWFumbGVdbV9X2-SKd-OQXfShvHu5BsGUXnQ_Vh3WfZ8CZlt8wOixD7kis30K_x_0D6urmEQ |
Cites_doi | 10.1016/j.revmed.2012.01.005 10.1681/ASN.V13142 10.1191/0961203303lu394oa 10.1136/ard.2008.096669 10.1111/j.1600-6143.2010.03233.x 10.1111/j.1538-7836.2006.01753.x 10.1016/j.transproceed.2004.12.151 10.1016/0272-6386(95)90656-8 10.2215/CJN.00460110 10.1177/0961203307084724 10.1016/j.nephro.2011.12.005 10.1681/ASN.2007030257 10.1182/blood.V98.6.1760 10.1002/art.10187 10.1046/j.1523-1755.2002.00500.x 10.1002/art.22663 10.1093/ndt/gfq356 10.1681/ASN.V103507 10.1016/j.revmed.2008.05.013 10.1038/ki.1995.352 10.1046/j.1523-1755.1999.00258.x 10.1182/blood-2011-03-340232 10.1159/000235941 10.1093/ndt/7.12.1194 10.1097/00041552-200103000-00004 10.1136/ard.2010.142042 10.1097/00007890-199901150-00015 10.1161/CIRCULATIONAHA.111.028522 10.1016/j.autrev.2010.08.005 10.1016/j.revmed.2012.01.007 10.1038/ki.2011.477 10.1177/0961203310395803 |
ContentType | Journal Article |
Copyright | 2013 Association Société de néphrologie 2015 INIST-CNRS Distributed under a Creative Commons Attribution 4.0 International License |
Copyright_xml | – notice: 2013 Association Société de néphrologie – notice: 2015 INIST-CNRS – notice: Distributed under a Creative Commons Attribution 4.0 International License |
DBID | IQODW AAYXX CITATION 1XC |
DOI | 10.1016/j.nephro.2013.07.368 |
DatabaseName | Pascal-Francis CrossRef Hyper Article en Ligne (HAL) |
DatabaseTitle | CrossRef |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Antiphospholipid syndrome in nephrology. Kidney damage and practical aspects of the management |
EISSN | 1872-9177 |
EndPage | 9 |
ExternalDocumentID | oai_HAL_hal_01791299v1 10_1016_j_nephro_2013_07_368 28130788 S1769725513004963 |
GroupedDBID | --K --M .~1 0R~ 123 1B1 1~. 1~5 4.4 457 4G. 53G 5VS 7-5 71M 8P~ AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAXUO ABBQC ABFNM ABLJU ABLVK ABMAC ABMZM ABXDB ABYKQ ACDAQ ACGFS ACRLP ADBBV ADEZE AEBSH AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGUBO AGYEJ AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AXJTR BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FIRID FNPLU G-Q GBLVA HVGLF HZ~ IHE J1W KOM LCYCR LN9 M41 MO0 N9A O-L O9- OAUVE OZT P-8 P-9 PC. Q38 RIG ROL RPZ SDF SDG SEM SES SSH SSZ T5K ~G- ABPIF ADALY FYGXN IPNFZ IQODW AAYXX AKRWK CITATION 1XC |
ID | FETCH-LOGICAL-c1648-24271cb700f47aa84fa13ea33e6917a862454e5c019c2c49b98ceb79462496cc3 |
IEDL.DBID | AIKHN |
ISSN | 1769-7255 |
IngestDate | Thu Sep 19 06:33:07 EDT 2024 Fri Aug 23 02:23:18 EDT 2024 Thu Nov 24 18:27:05 EST 2022 Fri Feb 23 02:22:21 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Traitement Treatment Dialyse Syndrome des antiphospholipides Transplantation Dialysis Néphropathie associée au syndrome des antiphospholipides Antiphospholipid syndrome Antiphospholipid syndrome nephropathy Immunopathologie Pathologie de l'appareil circulatoire Pathologie du rein Pathologie de l'appareil urinaire Pathologie des vaisseaux sanguins Néphropathie Lésion Prise en charge Hémopathie Urologie Greffe Maladie autoimmune Néphrologie Chirurgie Thrombocyte Conduite à tenir Rein Appareil urinaire |
Language | French |
License | CC BY 4.0 Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c1648-24271cb700f47aa84fa13ea33e6917a862454e5c019c2c49b98ceb79462496cc3 |
ORCID | 0000-0003-4846-6793 |
PMID | 24113198 |
PageCount | 9 |
ParticipantIDs | hal_primary_oai_HAL_hal_01791299v1 crossref_primary_10_1016_j_nephro_2013_07_368 pascalfrancis_primary_28130788 elsevier_sciencedirect_doi_10_1016_j_nephro_2013_07_368 |
PublicationCentury | 2000 |
PublicationDate | 2014-02 |
PublicationDateYYYYMMDD | 2014-02-01 |
PublicationDate_xml | – month: 02 year: 2014 text: 2014-02 |
PublicationDecade | 2010 |
PublicationPlace | Issy-les-Moulineaux |
PublicationPlace_xml | – name: Issy-les-Moulineaux |
PublicationTitle | Néphrologie & thérapeutique |
PublicationYear | 2014 |
Publisher | Elsevier SAS Elsevier Masson Elsevier Masson (jusqu'en 2022) / John Libbey Eurotext (à partir de 2023) |
Publisher_xml | – name: Elsevier SAS – name: Elsevier Masson – name: Elsevier Masson (jusqu'en 2022) / John Libbey Eurotext (à partir de 2023) |
References | Nzerue, Hewan-Lowe, Pierangeli, Harris (bib0010) 2002; 62 Saadoun, Piette, Wahl, Costedoat-Chalumeau (bib0110) 2012; 33 Serrano, García, Serrano, Ramírez, Alfaro, Lora (bib0165) 2012; 81 Sinico, Cavazzana, Nuzzo, Vianelli, Napodano, Scaini (bib0080) 2010; 5 Wahl, Perret-Guillaume, Piette (bib0125) 2008; 29 Ozmen, Danis, Akin, Batun (bib0170) 2009; 72 Pengo, Ruffatti, Legnani, Testa, Fierro, Marongiu (bib0025) 2011; 118 Erkan, Harrison, Levy, Peterson, Petri, Sammaritano (bib0105) 2007; 56 Daugas, Nochy, Huong, Duhaut, Beaufils, Caudwell (bib0090) 2002; 13 Roozbeh, Serati, Malekhoseini (bib0155) 2006; 9 Cervera, Piette, Font, Khamashta, Shoenfeld, Camps (bib0030) 2002; 46 Costedoat-Chalumeau, Arnaud, Saadoun, Chastre, Leroux, Cacoub (bib0060) 2012; 33 Bollée, Moulin, Martinez, Meulders, Rougier, Baumelou (bib0055) 2012; 8 Wahl, Saadi, Perret-Guillaume, Membre, Frederic, Devignes (bib0015) 2007; 13 Diz-Küçükkaya, Hacihanefioğlu, Yenerel, Turgut, Keskin, Nalçaci (bib0040) 2001; 98 Hereng, Lambert, Hachulla, Samor, Dubucquoi, Caron (bib0100) 2008; 17 Alchi, Griffiths, Jayne (bib0070) 2010; 25 Miyakis, Lockshin, Atsumi, Branch, Brey, Cervera (bib0005) 2006; 4 Gigante, Gasperini, Cianci, Barbano, Giannakakis, Di Donato (bib0130) 2009; 30 Canaud, Bienaimé, Noël, Royal, Alyanakian, Dautzenberg (bib0180) 2010; 10 Hill, Nochy (bib0095) 2007; 18 Prakash, Miller, Suki (bib0160) 1995; 26 Ducloux, Pellet, Fournier, Rebibou, Bresson-Vautrin, Racadot (bib0185) 1999; 67 Zuily, Regnault, Selton-Suty, Eschwège, Bruntz, Bode-Dotto (bib0035) 2011; 124 Daugas, Hachulla, Darnige (bib0075) 2012 Manns, Burgess, Parsons, Schaefer, Hyndman, Scott-Douglas (bib0150) 1999; 55 Brunet, Aillaud, San Marco, Philip-Joet, Dussol, Bernard (bib0145) 1995; 48 Vaidya (bib0175) 2005; 37 Ruiz-Irastorza, Cuadrado, Ruiz-Arruza, Brey, Crowther, Derksen (bib0020) 2011; 20 Ruffatti, Del Ross, Ciprian, Nuzzo, Rampudda, Bertero (bib0115) 2009; 68 Joseph, Radhakrishnan, Appel (bib0135) 2001; 10 Erkan, Espinosa, Cervera (bib0050) 2010; 10 Asherson, Cervera, de Groot, Erkan, Boffa, Piette (bib0045) 2003; 12 Ruffatti, Del Ross, Ciprian, Bertero, Sciascia, Salvatore (bib0120) 2011; 70 Chew, Lins, Daelemans, Zachee, De Clerck, Vermylen (bib0140) 1992; 7 Nochy, Daugas, Droz, Beaufils, Grünfeld, Piette (bib0085) 1999; 10 Erkan, Leibowitz, Berman, Lockshin (bib0065) 2002; 29 Ruffatti (10.1016/j.nephro.2013.07.368_bib0115) 2009; 68 Roozbeh (10.1016/j.nephro.2013.07.368_bib0155) 2006; 9 Vaidya (10.1016/j.nephro.2013.07.368_bib0175) 2005; 37 Erkan (10.1016/j.nephro.2013.07.368_bib0065) 2002; 29 Gigante (10.1016/j.nephro.2013.07.368_bib0130) 2009; 30 Nzerue (10.1016/j.nephro.2013.07.368_bib0010) 2002; 62 Joseph (10.1016/j.nephro.2013.07.368_bib0135) 2001; 10 Brunet (10.1016/j.nephro.2013.07.368_bib0145) 1995; 48 Asherson (10.1016/j.nephro.2013.07.368_bib0045) 2003; 12 Erkan (10.1016/j.nephro.2013.07.368_bib0105) 2007; 56 Wahl (10.1016/j.nephro.2013.07.368_bib0125) 2008; 29 Daugas (10.1016/j.nephro.2013.07.368_bib0090) 2002; 13 Ruffatti (10.1016/j.nephro.2013.07.368_bib0120) 2011; 70 Serrano (10.1016/j.nephro.2013.07.368_bib0165) 2012; 81 Miyakis (10.1016/j.nephro.2013.07.368_bib0005) 2006; 4 Wahl (10.1016/j.nephro.2013.07.368_bib0015) 2007; 13 Bollée (10.1016/j.nephro.2013.07.368_bib0055) 2012; 8 Cervera (10.1016/j.nephro.2013.07.368_bib0030) 2002; 46 Daugas (10.1016/j.nephro.2013.07.368_bib0075) 2012 Zuily (10.1016/j.nephro.2013.07.368_bib0035) 2011; 124 Saadoun (10.1016/j.nephro.2013.07.368_bib0110) 2012; 33 Diz-Küçükkaya (10.1016/j.nephro.2013.07.368_bib0040) 2001; 98 Nochy (10.1016/j.nephro.2013.07.368_bib0085) 1999; 10 Hill (10.1016/j.nephro.2013.07.368_bib0095) 2007; 18 Ducloux (10.1016/j.nephro.2013.07.368_bib0185) 1999; 67 Chew (10.1016/j.nephro.2013.07.368_bib0140) 1992; 7 Manns (10.1016/j.nephro.2013.07.368_bib0150) 1999; 55 Prakash (10.1016/j.nephro.2013.07.368_bib0160) 1995; 26 Erkan (10.1016/j.nephro.2013.07.368_bib0050) 2010; 10 Sinico (10.1016/j.nephro.2013.07.368_bib0080) 2010; 5 Ozmen (10.1016/j.nephro.2013.07.368_bib0170) 2009; 72 Costedoat-Chalumeau (10.1016/j.nephro.2013.07.368_bib0060) 2012; 33 Hereng (10.1016/j.nephro.2013.07.368_bib0100) 2008; 17 Canaud (10.1016/j.nephro.2013.07.368_bib0180) 2010; 10 Ruiz-Irastorza (10.1016/j.nephro.2013.07.368_bib0020) 2011; 20 Pengo (10.1016/j.nephro.2013.07.368_bib0025) 2011; 118 Alchi (10.1016/j.nephro.2013.07.368_bib0070) 2010; 25 |
References_xml | – volume: 13 start-page: 1 year: 2007 end-page: 11 ident: bib0015 article-title: Syndrome des antiphospholipides. Classification actuelle et indications thérapeutiques publication-title: Med Ther contributor: fullname: Devignes – volume: 18 start-page: 2461 year: 2007 end-page: 2464 ident: bib0095 article-title: Antiphospholipid syndrome in systemic lupus erythematosus publication-title: J Am Soc Nephrol contributor: fullname: Nochy – volume: 9 start-page: 26 year: 2006 end-page: 32 ident: bib0155 article-title: Arteriovenous fistula thrombosis in patients on regular hemodialysis: a report of 171 patients publication-title: Arch Iran Med contributor: fullname: Malekhoseini – volume: 118 start-page: 4714 year: 2011 end-page: 4718 ident: bib0025 article-title: Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study publication-title: Blood contributor: fullname: Marongiu – volume: 37 start-page: 650 year: 2005 end-page: 651 ident: bib0175 article-title: Management of end-stage renal disease patients with antiphospholipid antibody syndrome publication-title: Transplant Proc contributor: fullname: Vaidya – volume: 10 start-page: 2051 year: 2010 end-page: 2060 ident: bib0180 article-title: Severe vascular lesions and poor functional outcome in kidney transplant recipients with lupus anticoagulant antibodies publication-title: Am J Transplant contributor: fullname: Dautzenberg – volume: 62 start-page: 733 year: 2002 end-page: 744 ident: bib0010 article-title: “Black swan in the kidney”: renal involvement in the antiphospholipid antibody syndrome publication-title: Kidney Int contributor: fullname: Harris – volume: 124 start-page: 215 year: 2011 end-page: 224 ident: bib0035 article-title: Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: meta-analysis of echocardiographic studies publication-title: Circulation contributor: fullname: Bode-Dotto – volume: 13 start-page: 42 year: 2002 end-page: 52 ident: bib0090 article-title: Antiphospholipid syndrome nephropathy in systemic lupus erythematosus publication-title: J Am Soc Nephrol contributor: fullname: Caudwell – volume: 25 start-page: 3147 year: 2010 end-page: 3154 ident: bib0070 article-title: What nephrologists need to know about antiphospholipid syndrome publication-title: Nephrol Dial Transplant contributor: fullname: Jayne – volume: 5 start-page: 1211 year: 2010 end-page: 1217 ident: bib0080 article-title: Renal involvement in primary antiphospholipid syndrome: retrospective analysis of 160 patients publication-title: Clin J Am Soc Nephrol contributor: fullname: Scaini – volume: 7 start-page: 1194 year: 1992 end-page: 1198 ident: bib0140 article-title: Are antiphospholipid antibodies clinically relevant in dialysis patients? publication-title: Nephrol Dial Transplant contributor: fullname: Vermylen – volume: 55 start-page: 315 year: 1999 end-page: 320 ident: bib0150 article-title: Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients publication-title: Kidney Int contributor: fullname: Scott-Douglas – volume: 33 start-page: 194 year: 2012 end-page: 199 ident: bib0060 article-title: Catastrophic antiphospholipid syndrome publication-title: Rev Med Interne contributor: fullname: Cacoub – volume: 12 start-page: 530 year: 2003 end-page: 534 ident: bib0045 article-title: Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines publication-title: Lupus contributor: fullname: Piette – volume: 29 start-page: 843 year: 2002 end-page: 849 ident: bib0065 article-title: Perioperative medical management of antiphospholipid syndrome: hospital for special surgery experience, review of literature, and recommendations publication-title: J Rheumatol contributor: fullname: Lockshin – volume: 68 start-page: 397 year: 2009 end-page: 399 ident: bib0115 article-title: Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicentre, retrospective follow-up study publication-title: Ann Rheum Dis contributor: fullname: Bertero – volume: 10 start-page: 507 year: 1999 end-page: 518 ident: bib0085 article-title: The intrarenal vascular lesions associated with primary antiphospholipid syndrome publication-title: J Am Soc Nephrol contributor: fullname: Piette – volume: 30 start-page: 405 year: 2009 end-page: 412 ident: bib0130 article-title: Antiphospholipid antibodies and renal involvement publication-title: Am J Nephrol contributor: fullname: Di Donato – volume: 17 start-page: 11 year: 2008 end-page: 15 ident: bib0100 article-title: Influence of aspirin on the clinical outcomes of 103 antiphospholipid antibodies-positive patients publication-title: Lupus contributor: fullname: Caron – year: 2012 ident: bib0075 article-title: Atteintes rénales du syndrome des anticorps antiphospholipides contributor: fullname: Darnige – volume: 26 start-page: 347 year: 1995 end-page: 352 ident: bib0160 article-title: Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosis publication-title: Am J Kidney Dis contributor: fullname: Suki – volume: 46 start-page: 1019 year: 2002 end-page: 1027 ident: bib0030 article-title: Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients publication-title: Arthritis Rheum contributor: fullname: Camps – volume: 4 start-page: 295 year: 2006 end-page: 306 ident: bib0005 article-title: International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) publication-title: J Thromb Haemost contributor: fullname: Cervera – volume: 98 start-page: 1760 year: 2001 end-page: 1764 ident: bib0040 article-title: Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study publication-title: Blood contributor: fullname: Nalçaci – volume: 10 start-page: 175 year: 2001 end-page: 181 ident: bib0135 article-title: Antiphospholipid antibody syndrome and renal disease publication-title: Curr Opin Nephrol Hypertens contributor: fullname: Appel – volume: 20 start-page: 206 year: 2011 end-page: 218 ident: bib0020 article-title: Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies publication-title: Lupus contributor: fullname: Derksen – volume: 10 start-page: 74 year: 2010 end-page: 79 ident: bib0050 article-title: Catastrophic antiphospholipid syndrome: updated diagnostic algorithms publication-title: Autoimmun Rev contributor: fullname: Cervera – volume: 33 start-page: 217 year: 2012 end-page: 222 ident: bib0110 article-title: Management of antiphospholipid syndrome publication-title: Rev Med Interne contributor: fullname: Costedoat-Chalumeau – volume: 29 start-page: 731 year: 2008 end-page: 734 ident: bib0125 article-title: The management of thrombosis in the antiphospholipid antibody syndrome: insights from recent clinical trials and remaining unsolved issues publication-title: Rev Med Interne contributor: fullname: Piette – volume: 56 start-page: 2382 year: 2007 end-page: 2391 ident: bib0105 article-title: Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals publication-title: Arthritis Rheum contributor: fullname: Sammaritano – volume: 72 start-page: 193 year: 2009 end-page: 198 ident: bib0170 article-title: Anticardiolipin antibodies in hemodialysis patients with hepatitis C and their role in fistula failure publication-title: Clin Nephrol contributor: fullname: Batun – volume: 67 start-page: 90 year: 1999 end-page: 93 ident: bib0185 article-title: Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipients publication-title: Transplantation contributor: fullname: Racadot – volume: 81 start-page: 1239 year: 2012 end-page: 1244 ident: bib0165 article-title: IgA antibodies against β2 glycoprotein I in hemodialysis patients are an independent risk factor for mortality publication-title: Kidney Int contributor: fullname: Lora – volume: 48 start-page: 794 year: 1995 end-page: 800 ident: bib0145 article-title: Antiphospholipids in hemodialysis patients: relationship between lupus anticoagulant and thrombosis publication-title: Kidney Int contributor: fullname: Bernard – volume: 8 start-page: 168 year: 2012 end-page: 176 ident: bib0055 article-title: Renal biopsy practice: results of a French study and recommendations publication-title: Nephrol Ther contributor: fullname: Baumelou – volume: 70 start-page: 1083 year: 2011 end-page: 1086 ident: bib0120 article-title: Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study publication-title: Ann Rheum Dis contributor: fullname: Salvatore – volume: 33 start-page: 194 year: 2012 ident: 10.1016/j.nephro.2013.07.368_bib0060 article-title: Catastrophic antiphospholipid syndrome publication-title: Rev Med Interne doi: 10.1016/j.revmed.2012.01.005 contributor: fullname: Costedoat-Chalumeau – volume: 13 start-page: 42 year: 2002 ident: 10.1016/j.nephro.2013.07.368_bib0090 article-title: Antiphospholipid syndrome nephropathy in systemic lupus erythematosus publication-title: J Am Soc Nephrol doi: 10.1681/ASN.V13142 contributor: fullname: Daugas – volume: 12 start-page: 530 year: 2003 ident: 10.1016/j.nephro.2013.07.368_bib0045 article-title: Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines publication-title: Lupus doi: 10.1191/0961203303lu394oa contributor: fullname: Asherson – year: 2012 ident: 10.1016/j.nephro.2013.07.368_bib0075 contributor: fullname: Daugas – volume: 68 start-page: 397 year: 2009 ident: 10.1016/j.nephro.2013.07.368_bib0115 article-title: Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicentre, retrospective follow-up study publication-title: Ann Rheum Dis doi: 10.1136/ard.2008.096669 contributor: fullname: Ruffatti – volume: 10 start-page: 2051 year: 2010 ident: 10.1016/j.nephro.2013.07.368_bib0180 article-title: Severe vascular lesions and poor functional outcome in kidney transplant recipients with lupus anticoagulant antibodies publication-title: Am J Transplant doi: 10.1111/j.1600-6143.2010.03233.x contributor: fullname: Canaud – volume: 4 start-page: 295 year: 2006 ident: 10.1016/j.nephro.2013.07.368_bib0005 article-title: International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) publication-title: J Thromb Haemost doi: 10.1111/j.1538-7836.2006.01753.x contributor: fullname: Miyakis – volume: 37 start-page: 650 year: 2005 ident: 10.1016/j.nephro.2013.07.368_bib0175 article-title: Management of end-stage renal disease patients with antiphospholipid antibody syndrome publication-title: Transplant Proc doi: 10.1016/j.transproceed.2004.12.151 contributor: fullname: Vaidya – volume: 26 start-page: 347 year: 1995 ident: 10.1016/j.nephro.2013.07.368_bib0160 article-title: Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosis publication-title: Am J Kidney Dis doi: 10.1016/0272-6386(95)90656-8 contributor: fullname: Prakash – volume: 5 start-page: 1211 year: 2010 ident: 10.1016/j.nephro.2013.07.368_bib0080 article-title: Renal involvement in primary antiphospholipid syndrome: retrospective analysis of 160 patients publication-title: Clin J Am Soc Nephrol doi: 10.2215/CJN.00460110 contributor: fullname: Sinico – volume: 17 start-page: 11 year: 2008 ident: 10.1016/j.nephro.2013.07.368_bib0100 article-title: Influence of aspirin on the clinical outcomes of 103 antiphospholipid antibodies-positive patients publication-title: Lupus doi: 10.1177/0961203307084724 contributor: fullname: Hereng – volume: 8 start-page: 168 year: 2012 ident: 10.1016/j.nephro.2013.07.368_bib0055 article-title: Renal biopsy practice: results of a French study and recommendations publication-title: Nephrol Ther doi: 10.1016/j.nephro.2011.12.005 contributor: fullname: Bollée – volume: 18 start-page: 2461 year: 2007 ident: 10.1016/j.nephro.2013.07.368_bib0095 article-title: Antiphospholipid syndrome in systemic lupus erythematosus publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2007030257 contributor: fullname: Hill – volume: 98 start-page: 1760 year: 2001 ident: 10.1016/j.nephro.2013.07.368_bib0040 article-title: Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study publication-title: Blood doi: 10.1182/blood.V98.6.1760 contributor: fullname: Diz-Küçükkaya – volume: 46 start-page: 1019 year: 2002 ident: 10.1016/j.nephro.2013.07.368_bib0030 article-title: Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients publication-title: Arthritis Rheum doi: 10.1002/art.10187 contributor: fullname: Cervera – volume: 62 start-page: 733 year: 2002 ident: 10.1016/j.nephro.2013.07.368_bib0010 article-title: “Black swan in the kidney”: renal involvement in the antiphospholipid antibody syndrome publication-title: Kidney Int doi: 10.1046/j.1523-1755.2002.00500.x contributor: fullname: Nzerue – volume: 13 start-page: 1 year: 2007 ident: 10.1016/j.nephro.2013.07.368_bib0015 article-title: Syndrome des antiphospholipides. Classification actuelle et indications thérapeutiques publication-title: Med Ther contributor: fullname: Wahl – volume: 72 start-page: 193 year: 2009 ident: 10.1016/j.nephro.2013.07.368_bib0170 article-title: Anticardiolipin antibodies in hemodialysis patients with hepatitis C and their role in fistula failure publication-title: Clin Nephrol contributor: fullname: Ozmen – volume: 9 start-page: 26 year: 2006 ident: 10.1016/j.nephro.2013.07.368_bib0155 article-title: Arteriovenous fistula thrombosis in patients on regular hemodialysis: a report of 171 patients publication-title: Arch Iran Med contributor: fullname: Roozbeh – volume: 56 start-page: 2382 year: 2007 ident: 10.1016/j.nephro.2013.07.368_bib0105 article-title: Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals publication-title: Arthritis Rheum doi: 10.1002/art.22663 contributor: fullname: Erkan – volume: 25 start-page: 3147 year: 2010 ident: 10.1016/j.nephro.2013.07.368_bib0070 article-title: What nephrologists need to know about antiphospholipid syndrome publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gfq356 contributor: fullname: Alchi – volume: 10 start-page: 507 year: 1999 ident: 10.1016/j.nephro.2013.07.368_bib0085 article-title: The intrarenal vascular lesions associated with primary antiphospholipid syndrome publication-title: J Am Soc Nephrol doi: 10.1681/ASN.V103507 contributor: fullname: Nochy – volume: 29 start-page: 731 year: 2008 ident: 10.1016/j.nephro.2013.07.368_bib0125 article-title: The management of thrombosis in the antiphospholipid antibody syndrome: insights from recent clinical trials and remaining unsolved issues publication-title: Rev Med Interne doi: 10.1016/j.revmed.2008.05.013 contributor: fullname: Wahl – volume: 48 start-page: 794 year: 1995 ident: 10.1016/j.nephro.2013.07.368_bib0145 article-title: Antiphospholipids in hemodialysis patients: relationship between lupus anticoagulant and thrombosis publication-title: Kidney Int doi: 10.1038/ki.1995.352 contributor: fullname: Brunet – volume: 55 start-page: 315 year: 1999 ident: 10.1016/j.nephro.2013.07.368_bib0150 article-title: Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients publication-title: Kidney Int doi: 10.1046/j.1523-1755.1999.00258.x contributor: fullname: Manns – volume: 118 start-page: 4714 year: 2011 ident: 10.1016/j.nephro.2013.07.368_bib0025 article-title: Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study publication-title: Blood doi: 10.1182/blood-2011-03-340232 contributor: fullname: Pengo – volume: 29 start-page: 843 year: 2002 ident: 10.1016/j.nephro.2013.07.368_bib0065 article-title: Perioperative medical management of antiphospholipid syndrome: hospital for special surgery experience, review of literature, and recommendations publication-title: J Rheumatol contributor: fullname: Erkan – volume: 30 start-page: 405 year: 2009 ident: 10.1016/j.nephro.2013.07.368_bib0130 article-title: Antiphospholipid antibodies and renal involvement publication-title: Am J Nephrol doi: 10.1159/000235941 contributor: fullname: Gigante – volume: 7 start-page: 1194 year: 1992 ident: 10.1016/j.nephro.2013.07.368_bib0140 article-title: Are antiphospholipid antibodies clinically relevant in dialysis patients? publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/7.12.1194 contributor: fullname: Chew – volume: 10 start-page: 175 year: 2001 ident: 10.1016/j.nephro.2013.07.368_bib0135 article-title: Antiphospholipid antibody syndrome and renal disease publication-title: Curr Opin Nephrol Hypertens doi: 10.1097/00041552-200103000-00004 contributor: fullname: Joseph – volume: 70 start-page: 1083 year: 2011 ident: 10.1016/j.nephro.2013.07.368_bib0120 article-title: Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study publication-title: Ann Rheum Dis doi: 10.1136/ard.2010.142042 contributor: fullname: Ruffatti – volume: 67 start-page: 90 year: 1999 ident: 10.1016/j.nephro.2013.07.368_bib0185 article-title: Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipients publication-title: Transplantation doi: 10.1097/00007890-199901150-00015 contributor: fullname: Ducloux – volume: 124 start-page: 215 year: 2011 ident: 10.1016/j.nephro.2013.07.368_bib0035 article-title: Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: meta-analysis of echocardiographic studies publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.111.028522 contributor: fullname: Zuily – volume: 10 start-page: 74 year: 2010 ident: 10.1016/j.nephro.2013.07.368_bib0050 article-title: Catastrophic antiphospholipid syndrome: updated diagnostic algorithms publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2010.08.005 contributor: fullname: Erkan – volume: 33 start-page: 217 year: 2012 ident: 10.1016/j.nephro.2013.07.368_bib0110 article-title: Management of antiphospholipid syndrome publication-title: Rev Med Interne doi: 10.1016/j.revmed.2012.01.007 contributor: fullname: Saadoun – volume: 81 start-page: 1239 year: 2012 ident: 10.1016/j.nephro.2013.07.368_bib0165 article-title: IgA antibodies against β2 glycoprotein I in hemodialysis patients are an independent risk factor for mortality publication-title: Kidney Int doi: 10.1038/ki.2011.477 contributor: fullname: Serrano – volume: 20 start-page: 206 year: 2011 ident: 10.1016/j.nephro.2013.07.368_bib0020 article-title: Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies publication-title: Lupus doi: 10.1177/0961203310395803 contributor: fullname: Ruiz-Irastorza |
SSID | ssj0038411 |
Score | 1.8768578 |
Snippet | Le syndrome des antiphospholipides est une thrombophilie caractérisée par l’association d’un événement clinique thrombotique (artériel et/ou veineux) ou... The antiphospholipid syndrome is a thrombophilia characterized by the combination of arterial and/or venous thrombotic events or obstetric clinical events,... |
SourceID | hal crossref pascalfrancis elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 1 |
SubjectTerms | Anticoagulants Antihypertensive Agents Antiphospholipid Syndrome Antiphospholipid syndrome nephropathy Arterial Occlusive Diseases Biopsy Cardiovascular Diseases Contraindications Dialyse Dialysis Disease Management Female Humans Kidney Diseases Kidney Transplantation Life Sciences Middle Aged Nephrologie. Maladies des voies urinaires Nervous System Diseases Néphropathie associée au syndrome des antiphospholipides Platelet Aggregation Inhibitors Renal Artery Renal Circulation Renal Dialysis Renal Veins Santé publique et épidémiologie Sciences biologiques et medicales Sciences medicales Syndrome des antiphospholipides Thrombocytopenia Thrombophilia Thrombosis Thrombotic Microangiopathies Traitement Transplantation Treatment |
Title | Le syndrome des antiphospholipides en néphrologie. Atteinte rénale et aspects pratiques de la prise en charge |
URI | https://dx.doi.org/10.1016/j.nephro.2013.07.368 https://hal.univ-lorraine.fr/hal-01791299 |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fSxwxEB-8E0qhlFZbemqPUHxd7_aym-w-HlI5PfVBK_UtJNkET4695XbbR7-Pn8Mv5sz-EQVB8GFZNptMwi_DZIbMH4D9UAotwswHhvssiHCLgzQTNjBjj9ZCHFvPKcD57FzMrqKT6_h6Aw67WBhyq2xlfyPTa2ndtoxaNEfFYjG6xGlSOaECJaTmCt6DzfqSqA-b0-P57LwTyDyJ6jK81D-gAV0EXe3mlTsEjaIAQ05ZPDnlXH39hOrdkKvkp0KXiJ5vyl48O4uOvsDnVolk02adX2HDr7fgw1l7Tb4Nq1PHulQELHMlQ_gWxc2qxGe5oJqwJXM5yx_uaVUk_dwBm1ZU-LJybP1wj9QdcxXTdSBmyQriEzpBkBpbakbJEx2RqBMtuW9wdfT7z-EsaCsrBBbNo4TugWVojRyPfSS1TiKvQ-40506g-aYpaCSOXGxR_7MTG6UmTawzlIserTVhLf8O_XyVux_AjBFSei-1kAb_ZQbJGuF5mGU-9lk8gKBDUxVNAg3VeZbdqgZ9ReirsVSI_gBkB7l6wQgKZfwbI3_hDj1NQnmzZ9NTRW0kdlCxSf-HAxi-2MCn7pMEWUcmyc6759-Fj_gVNS7de9Cv1v_cT9RYKjOE3sFdOGz5kt7zi7_zRyMD7vI |
link.rule.ids | 230,315,783,787,888,4511,24130,27938,27939,45599,45693 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS-QwEB_8AD0QuQ-PWz29IPfa2-2mTdrHRU7qubsvKvgWkjTBlaVbtr37n_w7_Mduph-iIAg-9CVNJuGXYTIhM78B-BlKoUWY-8BwnwcRbnGQ5sIGZuTxthDH1nNKcJ7NRXYT_bmNbzfgrM-FobDKzva3Nr2x1l3LsENzWC4WwyucJpVjKlBCbq7gm7CN3kCKyr49ubjM5r1B5knUlOGl_gEN6DPomjCvwiFolAUYcmLx5MS5-voJtXlHoZJ7pa4QPd-WvXh2Fp1_hP3OiWSTdp2fYMOvP8POrHsm_wKrqWM9FQHLXcUQvkV5t6rwWy6oJmzFXMGKxwdaFVk_94tNaip8WTu2fnxA6Y65mukmEbNiJekJnSAojS01I_JERyIaoiV3ADfnv6_PsqCrrBBYvB4l9A4sQ2vkaOQjqXUSeR1ypzl3Aq9vmpJG4sjFFv0_O7ZRatLEOkNc9HhbE9byr7BVrAr3DZgxQkrvpRbS4L_coFgjPA_z3Mc-jwcQ9GiqsiXQUH1k2b1q0VeEvhpJhegPQPaQqxeKoNDGvzHyFHfoaRLizc4mU0VtZHbQsUn_hQM4ebGBT93HCeqRTJLDd8__A3az69lUTS_ml0fwAf9EbXj3d9iq13_dMXovtTnptPM_iSbvTA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Le+syndrome+des+antiphospholipides+en+n%C3%A9phrologie.+Atteinte+r%C3%A9nale+et+aspects+pratiques+de+la+prise+en+charge&rft.jtitle=N%C3%A9phrologie+%26+th%C3%A9rapeutique&rft.au=DEKEYSER%2C+Manon&rft.au=ZUILY%2C+St%C3%A9phane&rft.au=CHAMPIGNEULLE%2C+Jacqueline&rft.au=ESCHWEGE%2C+Val%C3%A9rie&rft.date=2014-02-01&rft.pub=Elsevier+Masson&rft.issn=1769-7255&rft.eissn=1872-9177&rft.volume=10&rft.issue=1&rft.spage=1&rft.epage=9&rft_id=info:doi/10.1016%2Fj.nephro.2013.07.368&rft.externalDBID=n%2Fa&rft.externalDocID=28130788 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1769-7255&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1769-7255&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1769-7255&client=summon |